Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Enzalutamide plus androgen deprivation therapy prolongs survival in men with met...
Prof Andrew Armstrong - Duke University, Durham, USA
Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-sensitive prostate cancer ( Prof Andrew Armstrong - Duke University, Durham, USA )
24 Sep 2021
Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve ef...
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve efficacy in ovarian, fallopian, peritoneal cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 Sep 2021
Drug combination shows promise in treatment-resistant advanced ovarian cancer
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Drug combination shows promise in treatment-resistant advanced ovarian cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 Sep 2021
Assessment of guideline adherence in breast cancer management among oncologists ...
Dr Bolanle Adegboyega - Lagos University Teaching Hospital, Lagos, Nigeria
Assessment of guideline adherence in breast cancer management among oncologists in Nigeria ( Dr Bolanle Adegboyega - Lagos University Teaching Hospital, Lagos, Nigeria )
23 Sep 2021
Challenges in first line ALK+ NSCLC and emerging data on ALK TKIs
Prof Sanjay Popat - The Royal Marsden Hospital, London, UK
Challenges in first line ALK+ NSCLC and emerging data on ALK TKIs ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )
23 Sep 2021
Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal c...
Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA
Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer ( Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA )
23 Sep 2021
Adding abiraterone acetate plus prednisolone to standard therapy lengthens survi...
Prof Nick James - The Institute of Cancer Research, London, UK
Adding abiraterone acetate plus prednisolone to standard therapy lengthens survival in non-metastatic high-risk prostate cancer ( Prof Nick James - The Institute of Cancer Research, London, UK )
23 Sep 2021
Welcome to APCCC 2021
Prof Silke Gillessen and Prof Aurelius Omlin
Welcome to APCCC 2021 ( Prof Silke Gillessen and Prof Aurelius Omlin )
23 Sep 2021
IMpower010: A Phase 3 study of atezolizumab vs best supportive care after adjuva...
Dr Enriqueta Felip - Vall d’Hebron University Hospital & Vall d’Hebron Institute...
IMpower010: A Phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC ( Dr Enriqueta Felip - Vall d’Hebron University Hospital & Vall d’Hebron Institute of Oncology, Barcelona, Spain )
23 Sep 2021
ESMO 2021 Roundup
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2021 Roundup ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
22 Sep 2021
Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refrac...
Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway
Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refractory multiple myeloma ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )
21 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 5
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer - ESMO 2021 Day 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
21 Sep 2021